Cabinet decision on confidential reimbursement pricesvdek: Secret reimbursement amounts for patent-protected medicines make care more expensive and do not bring any added value for the insured, delete the regulation

Ulrike Elsner, Chairwoman of the Association of Replacement Funds e. V. (vdek): Berlin – “We substitute health insurance companies are once again strongly calling on the federal government to refrain from the planned confidential reimbursement amounts for new patent-protected drugs in the…

Those